Skip to main content
. Author manuscript; available in PMC: 2020 May 25.
Published in final edited form as: Nat Med. 2019 Nov 25;25(12):1839–1842. doi: 10.1038/s41591-019-0653-6

Extended Data Fig. 7. Oncoprint of mutations identified in the Juvenile Xanthogranuloma cohort (n=55 patients).

Extended Data Fig. 7.

Results of whole exome and targeted DNA and RNA sequencing of non-LCH neoplasms. Each patient is represented in one column. Diagnosis (JXG), age category, and sequencing method are in the first 3 rows. Somatic mutations identified are in the lower rows and subdivided based on mutations known to activate kinases, affect the JNK/p38 MAP kinase pathway, or involve a diverse array of co-occurring pathways (shown on the right).